December 20, 2018Ionis Announces Plans for Management Transitions in 2020
December 6, 2018Biogen Exercises Option with Ionis to Develop and Commercialize Investigational Treatment BIIB067 for a Subtype of Familial Amyotrophic Lateral Sclerosis (ALS) Based on Positive Phase 1 Data
No upcoming events at this time...
We have numerous ongoing clinical trials designed to evaluate our drugs in a variety of health conditions. More »